What is Cory Laboratories?
Founded in 2003 and headquartered in Alsip, Illinois, Cory Laboratories has established itself as a leader in dental cleaning solutions. The company specializes in the manufacturing of innovative and high-quality dental cleaning products, including advanced bio/enzymatic tablet formulations and ultrasonic cleaners. These products are engineered for the effective removal of complex organics, soils, and permanent cements, catering to dental professionals who demand superior performance. Cory Laboratories is particularly recognized for introducing 2nd Generation Tablet Cleaners to the market, highlighting its commitment to technological advancement and product efficacy.
How much funding has Cory Laboratories raised?
Cory Laboratories has raised a total of $80K across 1 funding round:
Debt
$80K
Debt (2025): $80K with participation from Bank of America
Key Investors in Cory Laboratories
Bank of America
Bank of America is a leading financial institution that provides a wide range of banking and financial services. Their participation in this funding round suggests a focus on supporting established companies with significant growth potential.
What's next for Cory Laboratories?
With the recent substantial expansion capital, Cory Laboratories is poised for significant growth and operational scaling. The company's strategic focus will likely involve enhancing its manufacturing capabilities, expanding its distribution network, and potentially broadening its product portfolio within the dental hygiene sector. This investment at a critical Series B/C stage suggests a trajectory aimed at capturing a larger market share and solidifying its position as an innovator in dental cleaning technology. Future developments may include further research into bio-enzymatic solutions and advanced cleaning equipment.
See full Cory Laboratories company page
